Home > Insider Trading > Filing (0001225208-14-021194)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1183765	Threshold Pharmaceuticals Inc	THLD	Pharmaceutical Preparations (2834)	943409596

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1250409	W Jeffrey Bird	755 Page Mill Road, Suite A-200 Palo Alto CA 94304-1005		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-10-01	417,050	$2.05	4,942,055	No	4	X	Indirect	By Ltd Partnership (SHV)
Common Stock	Disposition	2014-10-01	226,657	$3.77	4,715,398	No	4	S	Indirect	By Ltd Partnership (SHV)
Common Stock	Acquisiton	2014-10-01	21,829	$2.05	256,009	No	4	X	Indirect	By Trust
Common Stock	Disposition	2014-10-01	11,863	$3.77	244,146	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	By Ltd Partnership (SHV)
No	4	S	Indirect	By Ltd Partnership (SHV)
No	4	X	Indirect	By Trust
No	4	S	Indirect	By Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant	Disposition	2014-10-01	417,050	$0.00	417,050	$2.05
Common Stock	Common Stock Warrant	Disposition	2014-10-01	21,829	$0.00	21,829	$2.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-10-05	2014-10-05	No	4	X	Indirect
0	2009-10-05	2014-10-05	No	4	X	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	919	Direct

Footnotes

Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a Managing Director of the General Partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
On October 1, 2014, the reporting person exercised a warrant to purchase shares of the issuer's common stock for $2.05 per share. In accordance with the terms of the warrant, the exercise price was paid on a net basis. The shares disposed of in column 4 represent the number of shares of common stock withheld by the issuer to pay the exercise price.
Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.